The current DRMA market cap is 2.47M. The company's latest EPS is USD -3.8196 and P/E is -0.32.
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -3.17M | -7.86M | -9.67M | -8.04M |
Net Income | -3.24M | -7.9M | -9.61M | -7.8M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 605k | 11.62M | 6.94M | 7.98M |
Total Liabilities | 3.78M | 1.52M | 922k | 1.62M |
Total Equity | -3.18M | 10.11M | 6.02M | 6.36M |
Market Cap | 2.47M |
Price to Earnings Ratio | -0.32 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.34 |
Price to Book Ratio | 0.4 |
Dividend Yield | - |
Shares Outstanding | 2.04M |
Average Volume (1 week) | 234.17k |
Average Volume (1 Month) | 478.74k |
52 Week Change | -81.77% |
52 Week High | 7.62 |
52 Week Low | 1.00 |
Spread (Intraday) | 0.01 (0.82%) |
Company Name | Dermata Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.dermatarx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions